BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32793544)

  • 21. PTSD in the COVID-19 Era.
    Chamaa F; Bahmad HF; Darwish B; Kobeissi JM; Hoballah M; Nassif SB; Ghandour Y; Saliba JP; Lawand N; Abou-Kheir W
    Curr Neuropharmacol; 2021; 19(12):2164-2179. PubMed ID: 33441072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and Adverse Social Determinants of Health.
    Alamilla SG; Cano MÁ
    Behav Med; 2022; 48(2):67-71. PubMed ID: 35318902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Social Drivers of Health During a Pandemic: Leveraging Knowledge Graphs and Population Trends in COVID-19.
    Bettencourt-Silva JH; Mulligan N; Jochim C; Yadav N; Sedlazek W; Lopez V; Gleize M
    Stud Health Technol Inform; 2020 Nov; 275():6-11. PubMed ID: 33227730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social Determinants of COVID-19 in Massachusetts, United States: An Ecological Study.
    Hawkins D
    J Prev Med Public Health; 2020 Jul; 53(4):220-227. PubMed ID: 32752590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.
    Baumer Y; Farmer N; Premeaux TA; Wallen GR; Powell-Wiley TM
    Front Public Health; 2020; 8():559312. PubMed ID: 33134238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
    Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
    Front Immunol; 2022; 13():834942. PubMed ID: 35450063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.
    Riou J; Althaus CL
    Euro Surveill; 2020 Jan; 25(4):. PubMed ID: 32019669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between What People Learned About COVID-19 Using Web Searches and Their Behavior Toward Public Health Guidelines: Empirical Infodemiology Study.
    Akpan IJ; Aguolu OG; Kobara YM; Razavi R; Akpan AA; Shanker M
    J Med Internet Res; 2021 Sep; 23(9):e28975. PubMed ID: 34280117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards.
    Khalatbari-Soltani S; Cumming RC; Delpierre C; Kelly-Irving M
    J Epidemiol Community Health; 2020 Aug; 74(8):620-623. PubMed ID: 32385126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel coronavirus pandemic: A clinical overview.
    Kaswa R; Govender I
    S Afr Fam Pract (2004); 2020 Jun; 62(1):e1-e5. PubMed ID: 32633997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic.
    Ping W; Zheng J; Niu X; Guo C; Zhang J; Yang H; Shi Y
    PLoS One; 2020; 15(6):e0234850. PubMed ID: 32555642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.
    Lin Q; Paykin S; Halpern D; Martinez-Cardoso A; Kolak M
    JAMA Netw Open; 2022 Mar; 5(3):e220984. PubMed ID: 35244703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 - Background and Health Sciences Library Response during the First Months of the Pandemic.
    Clifton VL; Flathers KM; Brigham TJ
    Med Ref Serv Q; 2021; 40(1):1-10. PubMed ID: 33625334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of social distancing on early SARS-CoV-2 transmission in the United States.
    Sanchez JN; Reyes GA; Martínez-López B; Johnson CK
    Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020.
    Pathak EB; Salemi JL; Sobers N; Menard J; Hambleton IR
    J Public Health Manag Pract; 2020; 26(4):325-333. PubMed ID: 32282440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.